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Objective: This study examines the outcomes of mitral valve repair in a defined group of patients with mitral
regurgitation caused by advanced myxomatous degeneration.
Methods: Advanced myxomatous degeneration of the mitral valve was defined as a degenerative process
whereby both leaflets are voluminous and aneurysmal and the mitral annulus diameter exceeds 40 mm and
has posterior displacement, as determined by means of echocardiographic analysis. Over a 16-year period, we
identified 183 patients who underwent valve repair in this subgroup of myxomatous degeneration. The repair con-
sisted of relocating the posterior mitral annulus to the endocardium of the left ventricle at the atrioventricular junc-
tion, correction of leaflet prolapse, and annuloplasty. Analysis of perioperative variables and postoperative
outcomes were undertaken. The mean follow-up was 5.9  4.2 years and complete.
Results: The patients’ mean age was 52 years, and 118 were men. All patients had mitral regurgitation preoper-
atively. There were no early and only 8 late deaths (2 valve-related deaths). The survival at 10 years was 92% 
3%. Six patients required reoperation on the mitral valve, 5 for recurrent severe mitral regurgitation. The freedom
from reoperation at 10 years was 93%  3%. Six patients had severe and 21 had moderate mitral regurgitation.
The freedom from recurrent moderate or severe mitral regurgitation at 10 years was 80%  5%. We could not
identify independent predictors of recurrent mitral regurgitation.
Conclusions:Mitral valve repair for advanced myxomatous degeneration on the mitral valve provides excellent
early functional results, but late recurrent regurgitation is common, despite correction of dilated and displaced
mitral annulus and leaflet prolapse.A
C
DCarpentier and associates1 described myxomatous degener-
ation and fibroelastic deficiency as 2 distinct degenerative
disorders that can cause mitral valve leaflet prolapse and mi-
tral regurgitation (MR). The pathologic spectrum of one of
these entities, the myxomatous degeneration of the mitral
valve, varies widely and does not necessarily correlate
well with the severity of mitral valve dysfunction. Thus
myxomatous degeneration can be limited to a single seg-
ment of the mitral valve and associated with severe MR,
whereas advanced myxomatous degeneration involving all
segments of the mitral valve can be associated with only
mild MR. However, patients with advanced myxomatous
degeneration of the mitral valve might also have severe
MR that requires surgical attention.Mitral valve repair is dif-
ficult because the degenerative process involves the mitral
annulus, the leaflets, the chordae tendineae, and sometimes
even the papillary muscles.2,3 The posterior mitral annulus
in patients with advanced myxomatous degeneration is often
posteriorly displaced, as described by Hutchins and col-
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tion are voluminous and aneurysmal, and the number of
prolapsing segments is proportional to the degree of dis-
placement of the mitral annulus.5 Some surgeons refer to
this entity as ‘‘Barlow’s disease’’ in honor of John Barlow,
who first described ‘‘aneurysmal protrusion’’ of the poste-
rior leaflet of the mitral valve.6
Prolapse of the central scallop of the posterior leaflet is the
most common lesion among patients referred for surgical
intervention for MR.7 However, in surgical series in which
mitral valve repair rates exceed 90% of all patients with
degenerative disease of the mitral valve, the incidence of bi-
leaflet prolapse is fairly high.7 In our experience the most
common cause of bileaflet prolapse is advanced myxoma-
tous degeneration of the mitral valve.
In this study we defined advanced myxomatous degener-
ation of the mitral valve and reviewed the clinical outcomes
of mitral valve repair in this subgroup of patients with MR.
MATERIALS AND METHODS
From August 1990 to November 2006, one of us (TED) operated on
1032 patients for isolated MR caused by degenerative disease of the mitral
valve at the Peter Munk Cardiac Centre. The clinical profile, echocardio-
graphic data, surgical pathology, and technique of repair were collected pro-
spectively and entered into a database. Carpentier’s classification was used
to describe the various segments of leaflet prolapse.8
Based on the results of intraoperative transesophageal echocardiography
(TEE), the degree of myxomatous changes (graded as mild, moderate, and
severe depending on the size and thickness of the leaflets), the prolapsing
segments, the systolic diameter of the mitral annulus measured by a 0,rdiovascular Surgery c Volume 136, Number 6 1503




ePTFE ¼ expanded polytetrafluoroethylene
MR ¼ mitral regurgitation
TEE ¼ transesophageal echocardiography
and the severity of MR was recorded.5,9 For the purpose of this study,
advanced myxomatous degeneration of the mitral valve was defined as
a degenerative process whereby both leaflets were thickened (3 mm),
voluminous, and aneurysmal; the mitral annulus diameter in systole was
40 mm or larger; and there was at least 5 mm of posterior displacement
of the mitral annulus, as determined by means of TEE analysis (Figure 1)
and verified at surgical intervention. The degree of annular displacement
was measured at the P2 level by using a 4-chamber midesophageal view
at 0 during systole.5,9
Of 1032 patients with degenerative mitral valve disease, mitral valve re-
pair was performed in 943 (91%), and replacement in 89 (9%). Advanced
myxomatous changes, extensive calcification of the mitral annulus, and
active infective endocarditis were the main reasons for mitral valve
replacement. Advanced myxomatous degeneration of the mitral valve
was present in 211 patients, and mitral valve repair was performed in 183
(86%) patients. Five patients had repairs attempted, but the valve was re-
placed at the same operation without serious perioperative complications.
Preoperative and perioperative characteristics of all patients who had mitral
valve repair for advanced myxomatous degeneration are shown in Tables 1
and 2. Our institutional research ethics board approved this study.
Operative Technique
Operations were carried out after achievement of general anesthesia with
cardiopulmonary bypass and mild hypothermia (34C). Myocardial protec-
tion was provided by means of intermittent antegrade cold blood cardiople-
gia. The mitral valve was exposed though a generous left atriotomy along
the interatrial groove, dome, and posterior wall of the left atrium. The entire
posterior leaflet was detached from its insertion in 154 patients and along P2
and P3 in 29 patients (Figure 2). Multiple interrupted 2-0 polyester sutures
were passed through the endocardium of the posterior wall of the left ven-
tricle, where the mitral annulus was supposed to be, and also through the
tissue between the ventricle and the displaced annulus (Figure 2). These su-
tures were later used to secure the annuloplasty ring or band. The posterior
leaflet was trimmed to reduce its height to approximately 12 mm, and all re-
maining secondary chordae tendineae were severed. The false commissures
were closed if they were more than 5 mm deep. Next, starting at the com-
missural areas and moving centrally, the posterior leaflet was sutured to
the endocardium of the left ventricle and displaced annulus with continuous
4-0 polypropylene sutures. This suture line was along the line where the an-
nuloplasty sutures had been placed in the endocardium of the left ventricle,
as shown in the lower panel of Figure 2. Excess tissue in the central portion
of P2 was resected as needed. Residual prolapse of the posterior leaflet was
corrected by creating new chords of 6-0 expanded polytetrafluoroethylene
(ePTFE) sutures. The prolapse of the anterior leaflet was corrected by cre-
ating numerous new chords of 5-0 ePTFE sutures. A single ePTFE suture
was used to create 4 to 6 pairs of chords, as previously described.10 Each
ePTFE chord was 1 to 2 mm apart. A rigid annuloplasty ring was used in
the first 14 patients, and then a flexible annuloplasty ring was used in the
following 30 patients; a flexible posterior band was used in the remaining
139 patients. During the first decade of this study, the selection of size of
the annuloplasty ring was based on the intertrigonal distance and area of
the anterior leaflet, but as we began to use a posterior band, those measure-
ments served only as an estimate, and the posterior annuloplasty sutures
were spaced in the band according to the distance they were spaced in the
endocardium of the ventricle. Because most of the posterior leaflet was su-
tured to the endocardium of the left ventricle, the length of the band along1504 The Journal of Thoracic and Cardiovascular Sthis area was similar to that of the reconstructed annulus because it would be
difficult to further reduce the length of the posterior annulus. Four patients
required reconstruction of the mitral annulus with an autologous pericardial
patch because of extensive annular calcification.11 Intraoperative TEE anal-
ysis was performed in all patients. No patient left the operating room with
more than mild MR or prolapse of any segment. All patients were anticoa-
gulated with warfarin sodium during the first 3 months to maintain an inter-
national normalized ratio of 2 to 3. Oral anticoagulation was discontinued
after 3 months unless the patients were in atrial fibrillation or had a thrombo-
embolic event.
Follow-up
Patients were followed by the referring cardiologist and contacted by our
research personnel every other year through a comprehensive questionnaire.
They were interviewed by telephone when the patient or the cardiologist re-
ported an adverse event. Echocardiographic studies were performed intrao-
peratively and before hospital discharge in all patients and at least every
second year, either in our institution or by the referring cardiologist, and
the results were collected prospectively. The clinical follow-up for this
study was closed on September 2007 and was 100% complete. The mean
clinical follow-up time was 5.9  4.2 years (range, 1–16 years). Most
patients had multiple echocardiographic studies, and all patients had at least
1 study during the year of follow-up. The mean echocardiographic follow-
up was 5.3  4.3 years (range, 1–16 years).
Statistical Analysis
All statistical analyses were conducted with SAS Version 9.1 software
for Windows (SAS Institute, Inc, Cary, NC). Categorical variables were an-
alyzed by using c2 analyses or the Fisher’s exact test and were expressed as
percentages. Continuous variables were expressed as means standard de-
viation, and means were compared with the Student t test or the Wilcoxon
FIGURE 1. Echocardiographic appearance of posterior displacement of
the mitral annulus. The arrow marked MA points to where the annulus
should be, and the arrow marked MA d points to the displaced annulus.
LA, Left atrium; LV, left ventricle.urgery c December 2008
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Drank test. Survival and freedom from morbid events were analyzed by using
the Kaplan–Meier method. Cox regression analysis with backward selection
was used to identify the multivariable and independent predictors of recur-
rent MR. The following variables were included: age at the time of the op-
eration in increments of 5 years, sex, left ventricular ejection fraction of less
than 40%, NewYork Heart Association functional class IV, coronary artery
disease, 4 or more prolapsed segments, anterior leaflet prolapse, mitral
annulus diameter of 46 mm or greater, posterior displacement of the mitral
annulus of 10 mm or greater, and type of annuloplasty (ring or band). Vari-
able retention in the models was set at a P value of .05.
Statement of Responsibility
The authors had full access to the data and take full responsibility for
their integrity. All authors have read and agreed to the manuscript as written.
RESULTS
There were no operative deaths. The postoperative com-
plications were re-exploration of the mediastinum for bleed-
ing in 10 patients, blood transfusion in 62 patients, and atrial
fibrillation in 69 patients. There was no perioperative myo-
cardial infarction, stroke, wound infection, renal failure, or
any other serious complication. There were 8 late deaths
(1 from stroke, 1 from anticoagulation-related hemorrhage,
and 6 non–valve- and non–cardiac-related deaths) figure 3
shows the patients’ long term survival. At the latest fol-
low-up contact, 170 patients still had their native mitral
valve, and 136 (80%) were in functional class I, 23 (14%)
were in class II, and 11 (6%) were in class III.
TABLE 1. Clinical profile
No. of patients 183
Age (y)





Marfan syndrome 9 (5)
Electrocardiogram
Sinus rhythm 153 (84)
Atrial fibrillation 29 (16)
Heart block 1





Left ventricular ejection fraction
>59% 114 (62)





Coronary artery disease 8 (4)
Hypertrophic obstructive cardiomyopathy 2 (1)
Atrial septal defect 6 (3)
Values are presented as number (percentage) unless otherwise shown.The Journal of Thoracic and CaSix patients required repeat mitral valve operations: 1 re-
repair and 5 replacements. All 6 survived. The median time
to reoperation was 55 months (range, 9–102 months). The
indications for reoperation were severe recurrent MR in 5
patients (1 with hemolysis) caused by fibrosis, retraction,
and stiffening of at least 1 leaflet in 3 patients; recurrent leaf-
let prolapse in 2 patients; and mitral stenosis caused by pan-
nus on a Duran annuloplasty ring and leaflets in 1 patient.
The freedom from reoperation at 1, 5, and 10 years was
99.4%  0.6%, 98.7%  0.9%, and 92.9%  3.0%,
respectively.
Fifteen patients had neurologic events: 1 patient died, 3 had
permanent deficits, and 11 had transient deficits. Five of those
patients had recurrent neurologic events, resulting in 1 perma-
nent deficit and 4 transient deficits. The freedom from throm-
boembolic complications at 1, 5, and 10 years was 95% 
1.6%, 92%  2%, and 88%  3%, respectively.
There were 6 anticoagulant-related hemorrhage events.
One of these was fatal, 2 required blood transfusions, and
TABLE 2. Perioperative variables
Preoperative echocardiographic data
Left atrial diameter (mm) 53  11
Mitral annular diameter (mm) 46  9
Posterior displacement of annulus (mm) 9.4  3.8
Prolapsed leaflets
Posterior leaflet 183 (100)
Anterior leaflet 126 (69)
No. of prolapsed segments*
1 or 2 13 (7)
3 or 4 76 (41)
5 or 6 94 (51)
Mitral valve repair
Correction of displaced annulus 183 (100)
Reconstruction of mitral annulus with patch 4 (2)
Chordal replacement with ePTFE 170 (93)
Ring/band annuloplasty
Carpentier ring 12 (6)
Duran ring 30 (16)







Tricuspid valve repair 2 (1)
Maze procedure for atrial fibrillation 17 (9)
Coronary artery bypass 8 (4)
Septal myectomy 2 (1)
Patch closure of atrial septal defect 6 (3)
Aortic clamp time (min) 76  19
Cardiopulmonary bypass time (min) 93  22
ICU stay (h) 37.5  28.0
Hospital stay (d) 7.4  6.2
Values are presented as number (percentage) unless otherwise shown. *P1, P2, P3, A1,
A2, and A3 of Carpentier’s classification (see Carpentier and colleagues8).rdiovascular Surgery c Volume 136, Number 6 1505
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D3 required no treatment. One of the 6 anticoagulant-related
hemorrhages occurred in that first 3-month period. This pa-
tient had a good outcome after hospitalization and blood
transfusion. The remaining 5 episodes occurred among 31
patients who were taking long-term oral anticoagulation.
Three patients required pacemaker insertion late postoper-
atively. There were no cases of infective endocarditis and no
cases of valve thrombosis. The freedom from valve-related
morbidity and mortality at 1, 5, and 10 years was 94% 
2%, 90%  2%, and 78%  4%, respectively, and the
event-free survival was 94%  1.6%, 89%  3%, and
75%  5%, respectively.
Transthoracic echocardiographic analysis done before
hospital discharge showed trace or no MR in 152 patients,
mild MR in 29 patients, and mild-to-moderate MR in 3 pa-
tients. During the follow-up, 6 patients had severe recurrent
MR, and 21 had moderate MR. Among the 32 patients with
residual mild MR at hospital discharge, 2 had severe and 4
had moderate MR during follow-up. New York Heart Asso-
ciation functional class IV, prolapse of 4 or more leaflets
segments, and annuloplasty band instead of a complete
ring were predictors of recurrent moderate or severe MR
FIGURE 2. Upper panel, Intraoperative photograph of posterior displace-
ment of the mitral annulus. Lower panel, placement of the sutures on the en-
docardium of the left ventricle and displaced mitral annulus (some sutures
were color enhanced for clarity).1506 The Journal of Thoracic and Cardiovascular Suby means of univariate analysis, but none of these variables
were significant by using Cox regression analysis. Five
patients who had severe MR underwent reoperation, and
1 died of cancer. One patient had progressive mitral stenosis
caused by excessive pannus on a Duran annuloplasty ring.12
Figure 4 shows the freedom from severe MR, and Figure 5
shows the freedom from severe and moderate MR.
The echocardiogram obtained before hospital discharge
revealed a mitral valve area of 2.82  0.81 cm2 and
a mean gradient across the valve of 2.3  1.3 mm Hg. The
mean mitral annulus diameter was 29.2 5.3 mm in systole.
The left ventricular ejection fraction was normal or mini-
mally impaired in 180 patients and moderately impaired in
3 patients. The left atrial diameter was 43  8 mm.
At the most recent follow-up, electrocardiographic analy-
sis showed sinus rhythm in 157 (86%) patients, atrial fibril-
lation or flutter in 23 (12%) patients, and paced beats in 3
(2%) patients.
DISCUSSION
Since Barlow’s initial description of mitral valve pro-
lapse,13 there has been much disparity among authors with
respect to terminology and the appropriate treatment for var-
ious subgroups of patients with degenerative mitral valve
disease and MR. Some surgeons use the term Barlow’s dis-
ease to describe myxomatous degeneration of the mitral
valve.14,15 However, myxomatous degeneration of the mi-
tral valve has a broad pathologic spectrum, and we prefer
to reserve the term Barlow’s disease only when there is
advanced myxomatous degeneration of the mitral valve, as
defined in this article. Several investigators described this
entity in terms similar to ours16,17 but did not make infer-
ences to the mechanism for the large annuli that are almost
invariably associated with this disease. We found a plausible
explanation in a seminal study by Hutchins and colleagues.4
These investigators postulated that the primary abnormality
FIGURE 3. Long-term survival of all patients.rgery c December 2008
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Dwas in fact a defect in the annulus fibrosus of the mitral
valve, with leaflet deformity occurring as a result of these an-
nular changes. In an autopsy study the authors examined 900
mitral valves and found a variation in the relationship be-
tween the mitral annulus, the left atrial wall, and the proxi-
mal wall of the left ventricle. There was a subset of 65
with a variant that the authors referred to as ‘‘disjunction’’
of the mitral annulus, where there was wide separation be-
tween the annulus and the left ventricular wall. There were
25 patients with myxomatous mitral valves, and of these,
there were only 2 who did not exhibit this mitral annular dis-
junction, but these hearts had ischemic changes to the papil-
lary muscles.4 The mechanism of the leaflet changes was
postulated to be from hypermobility of the tension apparatus
leading to increased mechanical stress on the leaflet tissue,
with subsequent thickening and elongation. Angelini and as-
sociates18,19 countered the interpretation of mitral annular
disjunction presented by Hutchins and colleagues.4 These
FIGURE 4. Freedom from recurrent severe mitral regurgitation (MR).
FIGURE 5. Freedom from recurrent moderate or severe mitral regurgita-
tion (MR).The Journal of Thoracic and Caauthors sectioned the entire mitral annulus of 13 hearts at
autopsy and found annular disjunction in 7 hearts without
myxomatous changes in the leaflets.18 They therefore
surmised that annular displacement was a normal anatomic
variant and was not responsible for the development of myx-
omatous mitral valve. Based on our experience, we believe
that both groups of investigators were correct. As previously
shown, the annulus fibrosus of the mitral valve is not a con-
tinuous fibrous structure from the lateral to the medial
fibrous trigones in most human subjects.18 Myxomatous dis-
ease of the mitral valve is a genetically mediated disorder
with variable pathologic expression.20 Thus the pathologic
expression of this genetic disorder is probably more severe
in individuals in whom the annulus fibrosus is incomplete,
such as in those with posterior displacement of the mitral
annulus. This displacement is further accentuated by the
increased leaflet volume and consequent increase in tension
(LaPlace’s law).
The diagnosis of advanced myxomatous degeneration
of the mitral valve, as defined in this study, can be easily
made by means of echocardiographic, particularly TEE,
analysis and confirmed at surgical intervention.5,9 Advanced
myxomatous degeneration is often a reason mitral valve
repair is not feasible in all patients with mitral valve pro-
lapse.15 Some patients have thick, fibrotic, and even calci-
fied leaflets, chordae tendineae, and papillary muscles,
preventing a good functional result after mitral valve repair.
However, as long as the anterior leaflet is pliable and the an-
nulus is not heavily calcified, repair is feasible and the func-
tion of the repaired valve is excellent in most patients, as
shown in the echocardiographic studies of our patients.
The role of the displaced mitral annulus on long-term out-
comes of mitral valve repair in these patients is unknown.
However, before we were aware of the study by Hutchins
and colleagues,4 advanced myxomatous degeneration was
a predictor of reoperation after mitral valve repair in our
experience.21 Since then, most patients with advanced myx-
omatous changes who were referred for surgical intervention
have undergone valve repair, and in our hands the probabil-
ity of repair during the past 2 decades was approximately
87%.
Patients with advanced myxomatous degeneration of the
mitral valve are usually younger than patients with isolated
prolapse of the posterior leaflet.2 The mean age in our series
was only 52 years, whereas in a previous report from our in-
stitution, the mean age in patients with isolated posterior
leaflet prolapse was 60 years.7 Consequently, these patients
are less likely to have associated cardiovascular and other
diseases, and the operative mortality and morbidity are
very low. In our series of 183 patients, there was no opera-
tive death or serious postoperative complication. Patients
with Marfan syndrome who have MR frequently have ad-
vanced myxomatous degeneration of the mitral valve.22 Al-
though there were only 9 patients with Marfan syndrome inrdiovascular Surgery c Volume 136, Number 6 1507
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they were not included because they also had aortic root an-
eurysms and were excluded from this study.
Multiple surgical approaches have been used to repair
these valves.14-17,22,23 Adams and coworkers16 used stan-
dard Carpentier techniques combined with large annulo-
plasty rings. Other groups used the edge-to-edge repair
combined with mitral annuloplasty.17,23 Flameng and asso-
ciates15 recently compared the results of mitral valve repair
of ‘‘Barlow disease’’ with ‘‘fibroelastic deficiency.’’ These
authors defined Barlow’s disease as ‘‘myxoid appearance of
the whole valve with excess tissue and a dilated annulus’’
and fibroelastic deficiency as ‘‘restriction of thickening to
the prolapsed area(s), the remaining valve tissue being
more transparent, not thickened, without excess tissue, and
the annulus being dilated or not.’’ Barlow’s disease was
an independent predictor of recurrent MR in their study,
and at 10 years, almost one half of the patients had recurrent
moderate or severe MR.
None of those reports addressed the issue of posterior
displacement of the mitral annulus; however, Flameng and
associates15 found that ‘‘nonuse of sliding plasty’’ was also
a predictor of recurrent MR after mitral valve repair. The sig-
nificance of posterior displacement of the mitral annulus in
mitral valve surgery remains largely unknown but correlates
well with the number of prolapsing segments of the leaflets5
and with the diameter of the mitral annulus. Displacement of
the mitral annulus can be localized to one segment, usually
Carpentier’s P2 segment,8 or as extensive as shown in Fig-
ure 2. Early on in our experience with mitral valve repair,
advancedmyxomatous degeneration emerged as an indepen-
dent predictor of repair failure.21 It was possible that the high
failure rate was due to inadequate annuloplasty; that is, the
ring or band was secured to the displaced annulus, and the
mechanical stresses on the leaflets and chordae were not
properly corrected. For this reason, we began to search for al-
ternative operative procedures and came across the study by
Hutchins and colleagues4 on posterior displacement of the
mitral annulus. We have addressed the issue of annular dis-
placement by detaching the posterior leaflet and reattaching
it to the endocardium of the proximal ventricular wall and se-
curing an annuloplasty band along the reconstructed area.
Because we suture the posterior leaflet and annuloplasty
band directly to the endocardium, there is a limit on how
much the length of the posterior annulus can be reduced.
We believe that reinforcement of the annular reconstruction
is vital to the success of this type of repair. Althoughwe favor
flexible bands to stabilize the reconstructed posterior annu-
lus, Carpentier and associates24 have extensive experience
with reattachment of the posterior leaflet to the endocardium
of the left ventricle in patients with a calcified annulus and
used exclusively rigid rings with excellent results.
Another aspect of our technique of repair that might
improve long-term durability is our liberal use of artificial1508 The Journal of Thoracic and Cardiovascular Schordae.10 We have more than 2 decades of experience
with chordal replacement with ePTFE sutures, and initially,
we used one 4-0 suture to create 2 new chords for approxi-
mately every centimeter of free margin of leaflet prolapse.
By 1995, we began using finer sutures (5-0 and 6-0) and
created 3 to 4 pairs of chords for every centimeter of free
margin of leaflet prolapse. The pairs were interdependent be-
cause they were created with a single suture by successively
passing it once through a fibrous portion of the papillary
muscle and twice through the free margin of the leaflet,
and the ends were tied on the papillary muscle head.10
This technique has allowed us to create up to 20 pairs of
new chords to anchor all segments of the mitral valve leaflets
with relative ease.
This study on the long-term results of mitral valve repair
in patients with MR caused by advanced myxomatous
degeneration of the mitral valve shows that valve repair is
durable but not as durable as for isolated prolapse of the
posterior leaflet.7 It compares more with outcomes of repair
for prolapse of both leaflets or anterior leaflet prolapse.7 Ac-
tually, most of our patients with advanced myxomatous de-
generation of the mitral valve had bileaflet prolapse. The
reoperation rate was low because only a few patients had se-
vere recurrentMR. However, a larger number of patients had
moderate MR during the follow-up, suggesting that mitral
valve repair might slow down but does not arrest the degen-
erative process. Based on our experience with only 6 reoper-
ations, the main cause of failure was fibrosis and retraction
of the mitral valve leaflets. We could not identify predictors
of recurrent MR by using a multivariable analysis, likely be-
cause of the complexity of this disease and its surgical cor-
rection. We might not have adequately assessed all variables
that can affect late operative outcomes. Recurrent MR in pa-
tients with degenerative disease has been documented by
means of echocardiographic analysis by Flameng and asso-
ciates.15,25 Those investigators found that recurrent MR was
more common in myxomatous disease than in fibroelastic
deficiency.15 Thus these patients should be followed with
annual echocardiographic studies to assess valve and left
ventricular size and function.
Limitations of the Study
This is a retrospective review of a clinical experience of
a single surgeon and is associated with all the shortcomings
of this type of study. We did not have a group of patients
with similar disease undergoing different techniques to as-
sess the importance of correcting the posterior annular dis-
placement. This report spans over a period of 16 years,
and although 1 surgeon performed all operations, the expe-
rience in treating these patients must have improved over the
years, and it is possible that patients undergoing surgical in-
tervention in recent years will have better outcomes than
those who underwent surgical intervention during the early
years, particularly during the last decade, when we beginurgery c December 2008
Newcomb et al Acquired Cardiovascular Diseaseto create many more ePTFE chords per prolapsing segment.
Finally, because this represents the experience of a single
surgeon, the results might not be generalized to all patients
with advanced myxomatous degeneration, and other sur-
geons using different techniques might provide better clini-
cal outcomes.
CONCLUSIONS
Mitral valve repair for MR caused by advanced myxoma-
tous degeneration of the mitral valve as defined in this study
is a complex operative procedure because the mitral annulus
is grossly dilated and displaced toward the atrium and the
leaflets are thickened and voluminous with prolapse of sev-
eral segments because of chordal elongation and sometimes
papillary muscle fibrosis and elongation. Correction of the
annular dilation and posterior displacement, shortening of
the height of the posterior leaflet, and prolapse correction
provided excellent functional results, but late recurrent
MR is common.
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